Major Late-Breaking Trials from EuroPCR 2025
<p class="moderator speaker-name">Anchorperson: <span classs="personname">Bernard Prendergast</span></p><p class="moderator speaker-name">Spokesperson: <span classs="personname">Thomas Cuisset</span></p><p class="moderator speaker-name">Discussants: <span classs="personname">Davide Capodanno, David Moliterno, Gilles Montalescot, Stephan Windecker</span></p>
<div class="intervention"><div class="interventionTitle">Introduction</div><p class="speaker-intervention-name-img">Bernard Prendergast</p></div><div class="intervention"><div class="interventionTitle">Tribute to Jean-Philippe Collet</div></div><div class="intervention"><div class="interventionTitle">Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies</div><p class="speaker-intervention-name-img">Rajesh Kharbanda</p></div><div class="intervention"><div class="interventionTitle">Study insights</div><p class="speaker-intervention-name-img">Davide Capodanno</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Clinical impact</div><p class="speaker-intervention-name-img">Davide Capodanno</p></div><div class="intervention"><div class="interventionTitle">Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial</div><p class="speaker-intervention-name-img">Flavio Luciano Ribichini</p></div><div class="intervention"><div class="interventionTitle">Study insights</div><p class="speaker-intervention-name-img">Stephan Windecker</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Clinical impact</div><p class="speaker-intervention-name-img">Stephan Windecker</p></div><div class="intervention"><div class="interventionTitle">One-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in Acute Coronary Syndrome</div><p class="speaker-intervention-name-img">Woong Chol Kang</p></div><div class="intervention"><div class="interventionTitle">Study insights</div><p class="speaker-intervention-name-img">Gilles Montalescot</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Clinical impact</div><p class="speaker-intervention-name-img">Gilles Montalescot</p></div><div class="intervention"><div class="interventionTitle">Conclusion</div><p class="speaker-intervention-name-img">Thomas Cuisset</p></div>
